Medtronic To Evaluate Drug-Eluting Stent For Erectile Dysfunction
This article was originally published in The Gray Sheet
Executive Summary
With the drug-eluting stent market more sluggish than it used to be, companies are looking for new ways to leverage the vascular technology. Medtronic signaled its interest last week in one such alternative for DES: erectile dysfunction